Related Experiment Video
Updated: Jul 4, 2026
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Delayed diagnosis in type 1 diabetes mellitus.
P C B Sundaram1, E Day, J M W Kirk
1Birmingham Children's Hospital, Birmingham, UK.
Archives of Disease in Childhood
|June 20, 2008
Summary
Immediate referral for children with suspected type 1 diabetes mellitus (T1DM) is crucial. Delayed diagnosis increases the risk of diabetic ketoacidosis (DKA) and higher HbA1c levels in pediatric patients.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Disorders
Background:
- Type 1 diabetes mellitus (T1DM) is a chronic condition requiring timely diagnosis and management in children.
- Delayed diagnosis in pediatric patients can lead to severe complications such as diabetic ketoacidosis (DKA).
- Effective management strategies for T1DM necessitate prompt identification and referral to specialized pediatric diabetes teams.
Purpose of the Study:
- To evaluate the impact of diagnostic delays on T1DM presentation in children.
- To highlight the importance of same-day referral for suspected pediatric T1DM cases.
- To identify factors contributing to delayed diagnosis and their consequences.
Main Methods:
- Retrospective analysis of 99 pediatric T1DM cases diagnosed between January 2004 and June 2007.
- Comparison of clinical presentation and diagnostic timelines between immediate referral and delayed diagnosis groups.
- Assessment of complication rates (DKA) and glycemic control (HbA1c) based on referral timing.
Main Results:
- 21.2% of children experienced diagnostic delays exceeding 24 hours.
- Delayed diagnosis was significantly associated with a higher incidence of DKA (52.3% vs 20.5%, p<0.01).
- Children with delayed diagnosis presented with higher median HbA1c levels (12.3% vs 10.9%, p<0.05).
Conclusions:
- Prompt referral to pediatric diabetes teams is essential for children with suspected T1DM.
- Healthcare providers must recognize T1DM symptoms to avoid diagnostic delays and prevent DKA.
- Timely diagnosis and management significantly improve outcomes for pediatric T1DM patients.
More Related Videos
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...